Unusual Response to Second-Line Single-Agent Gemcitabine in Locally Advanced Primary Leiomyosarcoma of the Lung: A Case Report

Journal of Chemotherapy

Volumn 15, Issue 5, 2003, Pages 507-509

  Silvestris, N ^a   Piscitelli, D ^b   Crucitta, E ^a   Fiore, M G ^b   De Lena, M ^a   Lorusso, V ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Gemcitabine; Leiomyosarcoma; Lung

Indexed keywords

ANTHRACYCLINE; EPIRUBICIN; GEMCITABINE; IFOSFAMIDE;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CASE REPORT; DRUG EFFICACY; DRUG INFUSION; HUMAN; LEIOMYOSARCOMA; LUNG SARCOMA; MALE; PATIENT CARE; SIDE EFFECT; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0142186011     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.5.507     Document Type: Article

References (15)

1. Dirix LY, Van Oosterom AT. Soft tissue sarcoma in adults. Curr Opin Oncol 1999; 11: 285-295.
2. Attanoos RL, Appleton MA, Gibbs AR. Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 14 cases. Histopathology 1996; 29: 29-36.
3. Moran CA, Suster S, Abbondanzo SL, Koss MN. Primary leiomyosarcomas of the lung: a clinicopathologic and immunohistochemical study of 18 cases. Mod Pathol 1997; 10: 121-128.
4. Sekine I, Kodama T, Yokose T et al. Rare pulmonary tumors - a review of 32 cases. Oncology 1998; 55: 431-434.
5. Keel SB, Bacha E, Mark EJ et al. Primary pulmonary sarcoma: a clinicopathologic study of 26 cases. Mod Pathol 1999; 12: 1124-1131.
6. Porte HL, Metois DG, Leroy X et al. Surgical treatment of primary sarcoma of the lung. Eur J Cardiothorac Surg 2000; 18: 136-142.
7. Magnè N, Porsin B, Pivot X et al. Primary lung sarcomas: long survivors obtained with iterative complete surgery. Lung Cancer 2001; 31: 241-245.
8. Plunkett W, Huang P, Xu YZ et al. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 1995; 22 (4 Suppl 11): 3-10.
9. Woll PJ, Judson I, Lee SM et al. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1999; 35: 410-412.
10. O'Byrne K, Steward WP. The role of chemotherapy in the treatment of adult soft tissue sarcomas. Oncology 1999; 56: 13-23.
11. Patel SR, Gandhi V, Jenkins J et al. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol 2001; 19: 3483-3489.
12. Merimsky O, Meller I, Flusser G et al. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. Cancer Chemother Pharmacol 2000; 45: 177-181.
13. Spath-Schwalbe E, Genvresse I, Koschuth A et al. Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas. Anticancer Drugs 2000; 11: 325-329.
14. Okuno S, Edmonson J, Mahoney M et al. Phase II trial of gemcitabine in advanced sarcomas. Cancer 2002; 94: 3225-3229.
15. Svancàrovà L, Blay JY, Judson IR et al. Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2002; 38: 556-559.